Brief: MiMedx Q2 Sales USD 81.257 Million Vs. IBES Estimate USD 74.8 Million
01/08/2023 21:01
Aug 01 (Reuters) - MiMedx Q2 gross profit USD 67.674 million. * Q2 adjusted EBITDA USD 14.102 million * Q2 operating income USD 2.788 million * Q2 EBITDA USD 3.634 million * Q2 net income USD 1.2 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million